AKT inhibitors

Details for Australian Patent Application No. 2010310786 (hide)

Owner Eli Lilly and Company

Inventors Beight, Douglas Wade; Burkholder, Timothy Paul; Clayton, Joshua Ryan; Eggen, MariJean; Henry, Kenneth James Junior; Johns, Deidre Michelle; Parthasarathy, Saravanan; Pei, Huaxing; Rempala, Mark Edward; Sawyer, Jason Scott

Agent Spruson & Ferguson

Pub. Number AU-A-2010310786

PCT Pub. Number WO2011/050016

Priority 61/254,308 23.10.09 US

Filing date 20 October 2010

Wipo publication date 28 April 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/050016 Priority application(s): WO2011/050016

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310788-Compositions and methods for controlling pupil dilation comprising phentolamine

2010310774-Nonvisual indication of an unwanted chemical in an ingestible substance